Search research articles
Contact Us
Filters
Showing results (261-270 of 270) with videos related to
Page
of 27
Sort By:
You have reached the last page of results.
This site can display upto 270 results.
The New England Journal of Medicine
|
May 6, 2026
Daraxonrasib in Previously Treated Advanced <i>RAS</i>-Mutated Pancreatic Cancer
Brian M Wolpin, Wungki Park, Ignacio Garrido-Laguna, et al.
Molecular Cancer Therapeutics
|
September 5, 2021
A Novel Antagonistic CD73 Antibody for Inhibition of the Immunosuppressive Adenosine Pathway
Melanie Wurm, Otmar Schaaf, Katharina Reutner, et al.
American Journal of Respiratory Cell and Molecular Biology
|
December 22, 2017
Nitric Oxide-Independent Soluble Guanylate Cyclase Activation Improves Vascular Function and Cardiac Remodeling in Sickle Cell Disease
Karin P Potoka, Katherine C Wood, Jeffrey J Baust, et al.
Global Change Biology
|
December 6, 2024
Preconditions for Including the Effects of Urease and Nitrification Inhibitors in Emission Inventories
Nicholas J Hutchings, Søren O Petersen, Karl G Richards, et al.
Journal of Medicinal Chemistry
|
May 31, 2017
Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart Failure
Markus Follmann, Jens Ackerstaff, Gorden Redlich, et al.
Cancer
|
March 12, 2026
A randomized phase II trial of gemcitabine, nab-paclitaxel, cisplatin with or without a medically supervised ketogenic diet for patients with metastatic pancreatic cancer
Gayle S Jameson, Denise J Roe, Erkut Borazanci, et al.
Journal of Medicinal Chemistry
|
April 11, 2023
New Generation of sGC Stimulators: Discovery of Imidazo[1,2-<i>a</i>]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension
Alexandros Vakalopoulos, Frank Wunder, Ingo V Hartung, et al.
Journal of Medicinal Chemistry
|
April 19, 2021
Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY 1101042)
Michael G Hahn, Thomas Lampe, Sherif El Sheikh, et al.
Acta Neuropathologica Communications
|
April 14, 2025
Integrated analysis of molecular and clinical features associated with overall survival in melanoma patients with brain metastasis
Swaminathan Kumar, Meredith S Pelster, Merve Hasanov, et al.
The New England Journal of Medicine
|
March 25, 2026
Setidegrasib in Advanced Non-Small-Cell Lung Cancer and Pancreatic Cancer
Wungki Park, Anup Kasi, Alexander I Spira, et al.
Page
of 27
Search research articles
Search
Showing results (261-270 of 270) with videos related to
Sort By:
Page
of 27
You have reached the last page of results.
This site can display upto 270 results.
The New England Journal of Medicine
|
May 6, 2026
Daraxonrasib in Previously Treated Advanced <i>RAS</i>-Mutated Pancreatic Cancer
Brian M Wolpin, Wungki Park, Ignacio Garrido-Laguna, et al.
Molecular Cancer Therapeutics
|
September 5, 2021
A Novel Antagonistic CD73 Antibody for Inhibition of the Immunosuppressive Adenosine Pathway
Melanie Wurm, Otmar Schaaf, Katharina Reutner, et al.
American Journal of Respiratory Cell and Molecular Biology
|
December 22, 2017
Nitric Oxide-Independent Soluble Guanylate Cyclase Activation Improves Vascular Function and Cardiac Remodeling in Sickle Cell Disease
Karin P Potoka, Katherine C Wood, Jeffrey J Baust, et al.
Global Change Biology
|
December 6, 2024
Preconditions for Including the Effects of Urease and Nitrification Inhibitors in Emission Inventories
Nicholas J Hutchings, Søren O Petersen, Karl G Richards, et al.
Journal of Medicinal Chemistry
|
May 31, 2017
Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart Failure
Markus Follmann, Jens Ackerstaff, Gorden Redlich, et al.
Cancer
|
March 12, 2026
A randomized phase II trial of gemcitabine, nab-paclitaxel, cisplatin with or without a medically supervised ketogenic diet for patients with metastatic pancreatic cancer
Gayle S Jameson, Denise J Roe, Erkut Borazanci, et al.
Journal of Medicinal Chemistry
|
April 11, 2023
New Generation of sGC Stimulators: Discovery of Imidazo[1,2-<i>a</i>]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension
Alexandros Vakalopoulos, Frank Wunder, Ingo V Hartung, et al.
Journal of Medicinal Chemistry
|
April 19, 2021
Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY 1101042)
Michael G Hahn, Thomas Lampe, Sherif El Sheikh, et al.
Acta Neuropathologica Communications
|
April 14, 2025
Integrated analysis of molecular and clinical features associated with overall survival in melanoma patients with brain metastasis
Swaminathan Kumar, Meredith S Pelster, Merve Hasanov, et al.
The New England Journal of Medicine
|
March 25, 2026
Setidegrasib in Advanced Non-Small-Cell Lung Cancer and Pancreatic Cancer
Wungki Park, Anup Kasi, Alexander I Spira, et al.
Page
of 27